Dong A St Beactica Therapeutics To Terminate Oncology Collaboration And Licensing Agreement

Dong A St Beactica Therapeutics To Terminate Oncology Collaboration And Licensing Agreement

Dong-A St Co., Ltd., A Korean Pharmaceutical Company, And Beactica Therapeutics Ab, A Swedish Precision Oncology Company, Announced That They Have Mutually Agreed To Terminate Their Collaboration And Licensing Agreement. The Collaboration Focused On Developing Novel Candidate Compounds Against Multiple Cancer Targets Of Mutual Interest. The Partnership Has Been Productive, And Multiple Compound Classes Are Now In Various Stages Of Lead Generation And Optimization.As Part Of The Termination, Both Dong-A St And Beactica Therapeutics Will Gain Exclusive Global Rights For Further Development And Commercialization For Different Compounds Series Developed During The Collaboration. No Obligations To Pay Milestone Payments Or Royalties Will Remain For The Assets Divided Between Dong-A And Beactica. For A Limited Time, Each Company Is Entitled To A Revenue Share From Any Related Future Outlicensing Activities By The Other Party. Full Financial Details Remain Undisclosed.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!